About ILCCO

General Study Description

study name
PI
Country
Institutes
Study
Case-control
Cohort
Case
Control
Current Target Current Target
no.
NORTH AMERICA
AG. Schwartz(1) US Wayne State University Pop CC 305 313 308 313
FHS AG. Schwartz(2) US Wayne State University Pop CC 702 702 871 870
Mayo 1 P. Yang(1) US Mayo Clinic Pop CC 400 400 2000 2000
UCSF JK Wiencke US UCSF Pop CC 1011 3543 900 4674
UCLA ZF. Zhang US UCLA Pop CC 600 600 600 600
WELD AG. Schwartz(3) US Wayne State University Pop CC 576 793 575 793
PLuSS B. Diegaarde US University of Pittsburgh Cancer Institute cohort 3754
NELCS EJ. Duell New Hampshire, US DHMC Pop CC 285 500 250 500
GTA J. McLaughlin Toronto, Canada SLRI Pop + Hosp. CC 516 516 660 600
NCI- Maryland CC. Harris / B. Ryan Baltimore, US NCI Pop + Hosp. CC 800 800 800 800
NY Multicenter Wynder, Muscat US Hosp. CC 5130 5130 4942 4942
MDACC MR Spitz, X Wu Texas, US MD Anderson Hosp. CC 3000 3000 3000 3000
HLCS DC. Christiani Boston, US Harvard Clinic CC 3300 3300 3300 3300
Mayo 2 P. Yang(2) US Mayo Clinic Hosp. CC 4000 4000 2000 2000
Tha Tampa Lung Cancer Study P. Lazarus Florida, US Moffitt Cancer Center Hosp. CC 500 500 910 910
M. Berwick US University of New Mexico Hosp. CC* 68 100 40 100
MSKCC-MP Orlow (1) New York, US MSKCC Hosp. CC 108 108 99 100
MSKCC-NS Orlow (2) New York, US MSKCC Hosp. CC 100 100 100 100
IELCAP-Toronto Liu Toronto, Canada PMH Hosp. CC 840 840 800 1000
Penn Whitehead Pennsilvania, US University of Pensilvania Hosp. CC 200 1200 150 1200
The Vanderbilt Lung Cancer Study (BioVU) M. Aldrich US Vanderbilt University Medical Center Hosp. CC 798 798 170000 170000
MSH-PMH Hung Toronto, Canada MSH-PMH Clinic CC 1200 1200 1200 1200
TLC Schabath Florida, US Moffitt Clinic CC 1000 4000 0 4000
WHI G. Ho US WHI Nested CC 1375 1607 161000
MEC Le Marchand US MEC Cohort 3912 192741
CPSII V. Stevens/MJ Thun US ACS cohort 150 184000
CARET GE. Goodman US FHCRC cohort 1445 18314
Yale Lung Cancer Biorepository B. E. Gould Rothberg US Yale U case cohort 583 1000
The Quebec City Lung Cancer Cohort Y. Bosse Canada Laval case cohort 4000 0 0 18314
EUROPE
Norway A. Haugen Norway NIOH, Norway Pop CC 2000 2000 2000 2000
Spain Lung Barros-Dios (1) Spain University of Santiago de Compostela Pop CC 163 163 241 500
EPIC P. Brennan / M. Johansson 10 European countries IARC, Imperial Cohort 5000 500000
GenAir P. Vineis 10 European countries Imperial College Nested CC 271 271 2977 2977  
IRCCS T. Dragani Italy IRCCS Pop CC, family 1000 1500 1000 1500
DCS H. Skuladottir Denmark Danish Cancer Society Pop CC 281 281 281 281
LLP JK. Field liverpool, UK University of Liverpool Pop CC 1500 1500 3000 3000
LUCY E. Wichmann Germany HMGU Pop CC 800 800 2000 2000
deCODE T. Rafnar Iceland deCODE Genetics Pop CC 633 800 3000 3000
ESTHER Brenner Saarland, Germany Pop CC 206 206 824 824
ICARE I. Stucker(1) France INSERM Pop CC 3000 3000 3000 3000
EAGLE MT. Landi Italy NCI Pop CC 2101 2000 2120 2000
The Nijmegen Lung Cancer Study Kiemeney The Netherlands Radboud University Nijmegen Medical Centre Pop CC 455 455 2000 2000
ReSOLUCENT P. Woll North Trent, UK University of Sheffield Medical School Pop CC + Family 48 450 58 450
Genova_Neri R Puntoni/M. Neri N. Italy National Cancer Research Institute Pop + Hosp. CC 350 350 460 460
Copenhagen S. Bojesen Copenhagen Copenhagen University Hospital Pop CC 1000 367 100000
INSERM S. Benhamou 10 Hospital (9 in Paris) France INSERM and Evry University Hosp. CC 151 151 171 171
LUCAS I. Stucker(2) Paris, E. France INSERM Hosp. CC 310 310 301 301
ICR R. Houlston Sutton, UK Institute of Cancer Research Clinic CC 5800 6000 5000 10000
DKFZ A. Risch Heidelberg and other regions, Germany DKFZ Hosp. CC 1200 1200 650 650
CE P. Boffetta,
P. Brennan
C/E.Europe IARC Hosp. CC 2861 2861 3118 3118
Barros-Dios (2) Spain University of Santiago de Compostela Hosp. CC 132 132 187 187
CAPUA Tardon Spain Universidad de Oviedo Hosp. CC 800 1200 840 1200
COLOGNE Wolf J Cologne, Germany Hosp. CC 350 1000 350 1000
Barros-Dios (3) Spain University of Santiago de Compostela Hosp. CC 447 447 538 538
Mayordomo_SpainAragon Mayordomo Aragon, Spain Hopital Clinico Universatorio Hosp. CC 470 470 2100 2100
NELSON Van Klaveren The Netherlands Erasmus U. cohort, screening 100 15850
Stricker The Netherlands Erasmus U. Cohort 176 14926
ASIA/OCEANIA
NICCC-LCA G. Rennert Israel CHS National Cancer control Center Pop CC 212 2000 197 2000
LAN2 Q. Lan (1) Xuan Wei county, Yunnan Province, China NCI Pop CC 500 500 500 500
YL. Qiao Yunnan, China Chinese Academy of Medical Sciences Pop CC 57 88 76 88
Hawaii L. Le Marchand(1) Island of Oahu, Hawaii, US U. Hawaii Pop CC 582 582 582 582
Kiyohara C. Kiyohara Japan Kyushu University Pop CC 192 192 130 130
Xuanwei_Lan Q. Lan(2) Xuan Wei county, Yunnan Province, China NCI Pop CC 122 122 122 122
NZ Aldington, Cox New Zealand Univeristy of Otago Pop CC 79 79 324 324
CLEAR K Canfell Australia CLEAR, Cancer Research Division Pop CC 311 2243
CJ. Chen Taiwan NTU Hosp. CC 1614 2000 1046 2000
Seow_Singapore A. Seow (1) Singapore National University of Singapore Hosp. CC 303 303 765 765
Aichi K. Mastuo, K. Tajima Aichi, Japan Aichi Cancer Center Hosp. CC 1557 1557 4085 4085
NCCRI Kohno Tokyo, Japan NCCRI, Japan Hosp. CC 4500 4500 4200 4200
Seoul Bundang Lung Cancer Study YC. Hong Seoul, Korea Seoul University Hosp. CC 1150 1150 1150 1150
NJLCS H. Shen Eastern China Nanjing Medical University School of Public Health Hosp. CC 2000 2000 2000 2000
C. A. Hsiung Taiwan National Health Research Institutes Hosp. CC 3555 3555 2939 2939
A. Seow (2) Singapore National University of Singapore Hosp. CC 400 400 800 800
L. Le Marchand(2) Hawaii, US U. Hawaii Cross-sectional 600 600
Singapore Chinese Health Study JM Yuan Singapore Puttsburg Cohort 1300 63257
Q. Lan(3) Xuan Wei county, Yunnan Province, China NCI Cohort 1600 1600 42663
Jie Zhang Shanghai, China Fudan U Shanghai Cancer Center case cohort 4040 5000
Total 92721 89113 253693 98576 1986505